| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/29/2011 | WO2011061744A3 Novel arylated camphenes, processes for their preparation and uses thereof |
| 09/29/2011 | WO2011059821A3 Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis |
| 09/29/2011 | WO2011056604A3 Treatment of sunburn using analgesics and antihistamines |
| 09/29/2011 | WO2011053825A3 Compositions and methods for the treatment or prevention of mitochondrial diseases |
| 09/29/2011 | WO2011009890A3 Use of azabicycloalkyl derivatives or pyrrolidine - 2 - one derivatives for the treatment or prevention of ataxia |
| 09/29/2011 | WO2010151815A3 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof |
| 09/29/2011 | WO2009123486A8 Use of compounds in the treatment of tau-induced cytotoxicities |
| 09/29/2011 | US20110239312 Methods of diagnosing and treating motor neuron diseases |
| 09/29/2011 | US20110239311 Agonists of NR2F6 For Immunosupression |
| 09/29/2011 | US20110238003 Method for systemic drug delivery through the nail |
| 09/29/2011 | US20110237792 Quinoline derivatives and their use as 5-ht6 ligands |
| 09/29/2011 | US20110237682 S1p receptor modulators for treating mutiple sclerosis |
| 09/29/2011 | US20110237681 Inhalable epinephrine |
| 09/29/2011 | US20110237680 Crystal forms of o-desmethylvenlafaxine fumarate |
| 09/29/2011 | US20110237670 Improvement of normal cognitive function |
| 09/29/2011 | US20110237669 Polyunsaturated Fatty Acids Interactions and Oxidative Stress Disorders |
| 09/29/2011 | US20110237668 Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy |
| 09/29/2011 | US20110237666 Hydroxybutyrate ester and medical use thereof |
| 09/29/2011 | US20110237659 Chromenone derivatives as trpv3 antagonists |
| 09/29/2011 | US20110237656 Method of Selectively Inhibiting the Activity of ACAT1 in the Treatment of Alzheimer's Disease |
| 09/29/2011 | US20110237651 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo |
| 09/29/2011 | US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf |
| 09/29/2011 | US20110237649 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1 |
| 09/29/2011 | US20110237646 Modulation of transthyretin expression for the treatment of cns related disorders |
| 09/29/2011 | US20110237645 USE OF RNAi TECHNOLOGY TO INHIBIT ASIC3 |
| 09/29/2011 | US20110237634 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 09/29/2011 | US20110237633 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 09/29/2011 | US20110237631 Selective Glycosidase Inhibitors and Uses Thereof |
| 09/29/2011 | US20110237627 Methods of synthesizing anatabine |
| 09/29/2011 | US20110237624 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 09/29/2011 | US20110237623 Sustained-release donepezil formulation |
| 09/29/2011 | US20110237622 Renin inhibitors |
| 09/29/2011 | US20110237618 Methods for treating migraines with huperzine a derivatives |
| 09/29/2011 | US20110237617 Thieno[2,3-c] isoquinolines for use as inhibitors of parp |
| 09/29/2011 | US20110237615 Narcotic Drug Formulations with Decreased Abuse Potential |
| 09/29/2011 | US20110237614 Pegylated Opioids with Low Potential for Abuse |
| 09/29/2011 | US20110237607 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| 09/29/2011 | US20110237602 Method for treating schizophrenia and related diseases |
| 09/29/2011 | US20110237600 Compounds for improving learning and memory |
| 09/29/2011 | US20110237597 Method of treating peripheral nerve sensory loss using compounds having nicotinic acetylcholine receptor activity |
| 09/29/2011 | US20110237596 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/29/2011 | US20110237595 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 09/29/2011 | US20110237589 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors |
| 09/29/2011 | US20110237586 Biaryl compositions and methods for modulating a kinase cascade |
| 09/29/2011 | US20110237583 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer |
| 09/29/2011 | US20110237582 Pyrido[3,4-b]indoles and methods of use |
| 09/29/2011 | US20110237581 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 09/29/2011 | US20110237580 Substituted bicyclic imidazole derivatives as gamma secretase modulators |
| 09/29/2011 | US20110237576 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having bace1-inhibiting activity |
| 09/29/2011 | US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 09/29/2011 | US20110237573 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators |
| 09/29/2011 | US20110237570 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors |
| 09/29/2011 | US20110237568 Crystalline forms |
| 09/29/2011 | US20110237567 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents |
| 09/29/2011 | US20110237564 Imidazopyrimidine derivatives |
| 09/29/2011 | US20110237561 Organic compounds |
| 09/29/2011 | US20110237557 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
| 09/29/2011 | US20110237556 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3 |
| 09/29/2011 | US20110237554 Combination therapies: inhibitors of GABA transaminase and NKCC1 |
| 09/29/2011 | US20110237546 Method for treating a mammal by administration of a compound having the ability to release co |
| 09/29/2011 | US20110237544 Novel Pharmaceutical Agents Containing Carbohydrate Moieties And Methods Of Their Preparation And Use |
| 09/29/2011 | US20110237538 Treatment of lysosomal storage disorders and other proteostatic diseases |
| 09/29/2011 | US20110237537 Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis |
| 09/29/2011 | US20110237536 Treating or Preventing Pain Using Spicamycin Derivatives |
| 09/29/2011 | US20110237515 Peptide derived from neurotesin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 09/29/2011 | US20110237496 Antinecrotic activity of alpha 1-antitrypsin |
| 09/29/2011 | US20110236994 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/29/2011 | US20110236512 Stress-reducing agent including plant-derived polyamine-containing extract serving as active component |
| 09/29/2011 | US20110236487 Solid ganaxolone formulations and methods for the making and use thereof |
| 09/29/2011 | US20110236463 Formulations for systemic buccal delivery comprising s-adenosylmethionine, their preparation and use |
| 09/29/2011 | US20110236439 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| 09/29/2011 | US20110236438 Method of treatment of diseases using hoodia extracts |
| 09/29/2011 | US20110236400 Tetrahydropyranochromene gamma secretase inhibitors |
| 09/29/2011 | US20110236371 Compositions And Methods For The Treatment Of Neurologic And Psychiatric Conditions |
| 09/29/2011 | US20110236365 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage |
| 09/29/2011 | US20110236358 Composition comprising isoflavones |
| 09/29/2011 | US20110236357 Bone marrow-derived mesenchymal stem cells as a source of neural progenitors |
| 09/29/2011 | US20110236356 Methods of isolating and using stem cells |
| 09/29/2011 | US20110236355 Differentiation of stem cells into dopaminergic cells |
| 09/29/2011 | US20110236352 PEGylation by the Dock and Lock (DNL) Technique |
| 09/29/2011 | US20110236350 Estrogen receptor ligand treatment for neurodegenerative diseases |
| 09/29/2011 | US20110236317 Tetrahydrotriazine compounds for treating diseases associated with ampk acitivity |
| 09/29/2011 | CA2800248A1 Compounds to be used in the treatment of diseases based on the expression of toxic transcripts |
| 09/29/2011 | CA2794004A1 Imaging agents for detecting neurological disorders |
| 09/29/2011 | CA2793725A1 Carboxamide bioisosteres of opiates |
| 09/29/2011 | CA2792339A1 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors |
| 09/29/2011 | CA2789900A1 Pharmaceutical composition comprising a pyrimidineone derivative |
| 09/29/2011 | CA2789778A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators |
| 09/29/2011 | CA2786213A1 N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as pde10a inhibitors |
| 09/28/2011 | EP2369516A2 Methods and apparatuses for assuring quality and safety of drug administration and medical products and kits |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368907A2 Anti-Abeta antibodies and their use |
| 09/28/2011 | EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 09/28/2011 | EP2368881A1 Heteropyrazole analogs acting on cannabinoid receptors |
| 09/28/2011 | EP2368876A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/28/2011 | EP2368563A1 Pharmaceutical composition containing GHRP-6 or GHRP-2 or hexarelin to prevent and eliminate fibrosis and other pathological deposits in tissues |
| 09/28/2011 | EP2368558A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
| 09/28/2011 | EP2367826A1 Modulators of amyloid beta. |
| 09/28/2011 | EP2367818A1 8-azabicyclo ý3.2.1¨oct-2-ene derivatives and their use as mono-amine neurotransmitter re-uptake inhibitors |
| 09/28/2011 | EP2367816A1 Isatin derivatives for use as in vivo imaging agents |